Retrospective Analysis of Heartworm (Dirofilia immitis) Prevention Medication Compliance and Economic Value in Dogs in Veterinary Practices in Australia
Background: Canine heartworm (HW) is endemic in Australia. Prevention usually involves monthly topical or oral preventives, or annual injections of extended-release moxidectin (ProHeart SR-12*1), hereafter referred to as injectable moxidectin (IM). Poor compliance can leave dogs susceptible to infec...
Main Authors: | Kennedy Mwacalimba, Andrea Wright, Konstantinos Giannakakis, Richard L'Estrange, Tinh-Son Nguyen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2020.602907/full |
Similar Items
-
Corrigendum: Retrospective Analysis of Heartworm (Dirofilia immitis) Prevention Medication Compliance and Economic Value in Dogs in Veterinary Practices in Australia
by: Kennedy Mwacalimba, et al.
Published: (2021-10-01) -
Pharmacoeconomic Analysis of Heartworm Preventive Compliance and Revenue in Veterinary Practices in the United States
by: Kennedy Mwacalimba, et al.
Published: (2021-05-01) -
Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
by: Tom L. McTier, et al.
Published: (2019-09-01) -
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
by: Tom L. McTier, et al.
Published: (2019-07-01) -
Moxidectin steady state prior to inoculation protects cats from subsequent, repeated infection with Dirofilaria immitis
by: Susan E Little, et al.
Published: (2015-02-01)